XML 19 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Cash flows from operating activities:          
Net (loss) income     $ (137) $ 540  
Adjustments to reconcile net (loss) income to net cash used in operating activities:          
Loan loss provision recaptures     (301) (1,000)  
Provision for losses on REOs     13 45  
Depreciation     171 181  
Net amortization of deferred loan origination costs     160 323  
Net amortization of premiums on mortgage-backed securities     19 26  
Amortization of investment in affordable housing limited partnership $ 36 $ 49 134 146  
ESOP compensation expense 19 19 47 67  
Earnings on bank owned life insurance     (39) (39)  
Originations of loans receivable held for sale 0 (20,300) (15,182) (20,288)  
Proceeds from sales of loans receivable held for sale     22,970 6,614  
Repayments on loans receivable held for sale     103 106  
Gain on sale of loans receivable held for sale     (204) (20)  
Change in assets and liabilities:          
Net change in deferred taxes     (209) 348  
Net change in accrued interest receivable     (39) (168)  
Net change in other assets     5 19  
Net change in advance payments by borrowers for taxes and insurance     473 449  
Net change in accrued expenses and other liabilities     322 436  
Net cash provided by (used in) operating activities     8,540 (12,108)  
Cash flows from investing activities:          
Net change in loans receivable held for investment     (8,735) (2,873)  
Principal payments on available-for-sale securities     1,450 1,760  
Proceeds from sales of REO     820    
Purchase of office properties and equipment     (33) (71)  
Net cash used in investing activities     (6,498) (1,184)  
Cash flows from financing activities:          
Net change in deposits     (1,347) (12,405)  
Proceeds from FHLB advances     13,000 34,500  
Repayments of FHLB advances     (8,000) (17,500)  
Payment for tax withholding for vesting of restricted stock     (14) (108)  
Repayments of junior subordinated debentures     (510)    
Net cash provided by financing activities     3,129 4,487  
Net change in cash and cash equivalents     5,171 (8,805)  
Cash and cash equivalents at beginning of the period     16,651 22,219 $ 22,219
Cash and cash equivalents at end of the period $ 21,822 $ 13,414 21,822 13,414 $ 16,651
Supplemental disclosures of cash flow information:          
Cash paid for interest     4,710 3,357  
Cash paid for income taxes     13    
Supplemental disclosures of non-cash investing and financing:          
Transfers of loans receivable held for sale to loans receivable held for investment     1,064 16,871  
Transfers of loans receivable held for investment to loans receivable held for sale     10,684    
Common stock exchanged for payment of tax withholding     14 108  
Initial Recognition of Operating Lease Right-to-Use Assets     1,120    
Initial Recognition of Operating Lease Liabilities     1,120    
Directors          
Adjustments to reconcile net (loss) income to net cash used in operating activities:          
Stock-based compensation expense     52 45  
Employees, excluding Directors          
Adjustments to reconcile net (loss) income to net cash used in operating activities:          
Stock-based compensation expense     $ 182 $ 62